Frost & Sullivan Research Service   Published: 24 Feb 2016
US Autoimmune Disease Diagnostics Market, Forecast to 2020
  SERVICE HOMEPAGE
FURTHER INFORMATION
  Table Of Contents
  1 | US AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, FORECAST TO 2020
   Executive Summary
      1. Scope and Segmentation
      2. Key Predictions: US Autoimmune Disease Diagnostics Market
      3. Current Trends in the Autoimmune Disease Diagnostics Market
      4. Autoimmune Disease Diagnostics Market—Overview
      5. Key Companies to Watch

  Competitive Overview
      1. Ecosystem of the Autoimmune Disease Diagnostics Market
      2. Significance of the Autoimmune Disease Diagnostics Market
      3. Significance of the Autoimmune Disease Diagnostics Market—Prevalence Rates
      4. Competitive Landscape
      5. Key Diseases and Available Solutions in the US Market
      6. Key Diseases and Available Solutions in the US Market (continued)
      7. LDTs—Role in Autoimmune Disease Diagnostics
      8. Segment Lifecycle Analysis by Disease
      9. Overall Market Forecast
      10. Overall Disease Segment Share
      11. Competitive SWOT Analysis by Company
      12. Competitive SWOT Analysis by Company (continued)

  Growth Opportunities
      1. Where do the Opportunities Lie in this Market?
      2. Pharma and Diagnostics Business Integration
      3. Autoimmune Diagnostics Companies are Uniting with Pharmaceuticals to Diversify Revenue Channels
      4. Direct-to-Consumer Market: The Risk and The Opportunity

  Localized Disease Diagnostics Segment
      1. Localized Disease Diagnostics Segment Revenue
      2. Growth Rate by Localized Autoimmune Diseases
      3. Competitive Value Matrix—Localized Disease Diagnostics Segment
      4. Autoimmune Tests—Role in Patient Continuum

  Systemic Disease Diagnostics Segment
      1. Systemic Disease Diagnostics Segment Revenue
      2. Growth Rate by Systemic Autoimmune Diseases
      3. Competitive Value Matrix—Systemic Disease Diagnostics Segment
      4. Autoimmune Tests—Role in Patient Continuum

  Conclusion
      1. Key Conclusions and Future Outlook
      2. Legal Disclaimer

  Appendix—List of LDTs
      1. Celiac Disease-specific LDT Assays
      2. Chron’s Disease-specific LDT Assays
      3. RA-specific LDT Assays
      4. Lupus-specific LDT Assays
      5. IBD/IBS-specific LDT Assays
      6. Others
      7. Learn More—Next Steps
      8. List of Exhibits
      9. List of Exhibits (continued)
      10. List of Exhibits (continued)

  The Frost & Sullivan Story
      1. The Frost & Sullivan Story
      2. Value Proposition: Future of Your Company & Career
      3. Global Perspective
      4. Industry Convergence
      5. 360º Research Perspective
      6. Implementation Excellence
      7. Our Blue Ocean Strategy

Conseq